Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia

British Journal of Haematology

Volumn 115, Issue 2, 2001, Pages 257-262

  Sargent, Jean M ^a   Williamson, Christine J ^a   Maliepaard, Marc ^a   Elgie, Alena W ^b   Scheper, Rik J ^c   Taylor, Colin G ^d  

^a DIVISION OF REPRODUCTIVE BIOLOGY   (United States)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c RESEARCH AND DEVELOPMENT   (Australia)

^d Pembury Hospital   (United Kingdom)

Author keywords

AML; BCRP; BXP 34; Chemo sensitivity; Drug resistance

Indexed keywords

DAUNORUBICIN; DOXORUBICIN; MITOXANTRONE; TOPOTECAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BLAST CELL; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER RESISTANCE; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG DETERMINATION; DRUG EFFECT; DRUG SCREENING; DRUG SENSITIVITY; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LC 50; MALE; MEMBRANE TRANSPORT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SAMPLING;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ATP-BINDING CASSETTE TRANSPORTERS; DAUNORUBICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKEMIA, MYELOID; MIDDLE AGED; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED;

EID: 0035726216     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.03122.x     Document Type: Article

References (14)

1. A multidrug transporter from human MCF-7 breast cancer cells
2. An in vitro study of blast cell metabolism in acute myeloid leukaemia using the MTT assay
3. Comparison of P-glycoprotein expression and function with in vitro sensitivity to anthracyclines in AML
4. The H.E.R. & tyrosine kinase inhibitor, C.I. 1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamp-tothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux
5. In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia
6. Acute myeloid leukemia in the elderly: Assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biological subgroups with remarkably distinct responses to standard chemotherapy. A South West Oncology study
7. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line
8. Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the, BCRP and inhibitor GF 120918
9. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein
10. Novel mechanisms of drug resistance in leukemia
11. Expression of breast cancer resistance protein in blast cells from patients with acute leukemia
12. Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia
13. Circumvention of resistance to ara C. and by aphidicolin in blast cells from patients with AML
14. Breast cancer resistance protein is localised at the plasma cell membrane in mitoxantrone- and topotecan-resistant cell lines